News | June 23, 2015

Munich hospital using combined system for precision treatment of wide range of cancers

Brainlab, Exactrac, Elekta, Versa HD, LMU Medical Center, Munich

June 23, 2015 - Brainlab announced first patient treatments in March on a fully integrated radiation oncology solution that combines its ExacTrac patient positioning with the Elekta Versa HD linear accelerator (LINAC). Working in synergy, these technologies determine positioning and treatment accuracy for cancer patients.  

By streamlining treatment workflow, ExacTrac and Versa HD increase patient positioning efficiency and provide highly accurate solutions for frameless stereotactic radiosurgery (SRS) and stereotactic body radiotherapy treatment (SBRT). The accuracy is further enriched with the ability to detect and manage intra-fractional patient motion during treatment delivery.

The integrated ExacTrac/Versa HD solution is currently in routine clinical use at Ludwig-Maximilian University Hospital in Munich. To date, the hospital has treated 12 patients with a range of indications and has plans to expand their ExacTrac/Versa HD program.

"The LMU Medical Center prides itself on offering advanced technology and finding new ways to optimize our existing infrastructure. Combining these innovative cancer treatment technologies - Brainlab ExacTrac and Elekta Versa HD - allows us to maximize the benefits of both systems for our patients, including intra-fractional verification," said Prof. Claus Belka, medical director of radiotherapy and radiation oncology at LMU Medical Center, Grosshadern and Innenstadt clinics and polyclinics. "The integrated solution allows us to perform SRS and SBRT cases with submillimetric accuracy and the seamless workflow has allowed us to provide comfortable and fast treatment for patients."

The combined systems enable treatment of conventional as well as complex cancers that require highly accurate targeting precision, expanding the reach and richness of SRS and SBRT for facilities looking to leverage resources and deliver advanced, sophisticated therapies across several different LINACs.

For more information: www.brainlab.com


Related Content

News | Radiation Oncology

May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...

Time May 03, 2025
arrow
News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
News | Radiology Business

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...

Time April 17, 2025
arrow
News | ASTRO

March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...

Time March 17, 2025
arrow
News | Computed Tomography (CT)

Royal Philips recently received 510(k) clearance from the US Food and Drug Administration (FDA) for its detector-based ...

Time November 13, 2024
arrow
News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
Subscribe Now